Sabinsa

Shaheen Majeed on continuing his father’s legacy, expanding the portfolio and our over-reliance on China

09-Apr-2024 By Stephen Daniells

Recently named as the CEO of Sami-Sabinsa Group, Shaheen Majeed said his late father left a simple and brilliant recipe for the next generation to follow: “Science and quality. Be reliable, be responsible.”

Anju and Shaheen Majeed to lead Sami-Sabinsa Group

01-Apr-2024 By Asia Sherman

Multi-national health sciences company Sami-Sabinsa announced that Dr. Muhammed Majeed’s children will carry on their father’s legacy at the helm of the business he founded 36 years ago. Dr. Majeed died March 13 at age 75 following complications from...

Industry remembers ‘Father of Indian Nutraceuticals’ Dr. Muhammad Majeed

21-Mar-2024 By Danielle Masterson

For many, it was another year at Expo West. But behind all the hustle and bustle, the dietary supplement industry was grieving the loss of a man many refer to as a mentor, a father figure and an industry icon. Dr. Muhammad Majeed brought more than just...

ANVISA approves first tetrahydrocurcuminoid for use in Brazil

19-Jan-2024 By Asia Sherman

Natural ingredient supplier Sabinsa announced this week that The Brazilian Health Regulatory Agency (ANVISA) has green-lighted its Curcumin C3 Reduct as health ingredient in the country.

Sami-Sabinsa inaugurates new manufacturing facility for global growth

04-Apr-2023 By Asia Sherman

Sami-Sabinsa Group – parent company to nutraceutical health supplement and herbal extract supplier Sabinsa – inaugurated a new state-of-the-art manufacturing facility in the city of Hassan in southern India.

Sabinsa study elucidates blood sugar benefits of amla ingredient

13-Feb-2023 By Nikki Hancocks

Pharmaceutical corporation Sabinsa completed a 90 day, multicentric randomised open label trial of its Amla, aka Indian gooseberry, extract and concluded it could provide blood sugar benefits.

Sabinsa mourns passing of CEO V.G. Nair

07-Jul-2022

Dr. Muhammed Majeed, Sami-Sabinsa Group’s founder, Chairman, and Managing Director, has expressed his sadness at the death of the group’s CEO, V.G. Nair.

Novel Foods approval has “burnished the image” of curcuminoid ingredient

21-Feb-2022 By Lynda Searby

Sabinsa has secured Novel Food approval for its patented curcuminoid metabolite ingredient C3 Reduct, giving supplement manufacturers in Europe a bioavailable curcuminoid option.

PEOPLE ON THE MOVE

Industry Movers: Glanbia Nutritionals, Sabinsa & J&J

27-Sep-2021 By Will Chu

September 2021 and while the nights draw in and the temperature drops, opportunities in the food and nutrition sector remain red-hot as NutraIngredients features those seeking a new challenge.

Cardioprotective properties found in pterostilbene: Study

19-Nov-2019 By Danielle Masterson

Sabinsa researchers and academic scientists released a new study that links the polyphenol to heart health.

Clinical trial finds curcuminoids plus piperine improve non-alcoholic fatty liver disease

01-Nov-2019 By Danielle Masterson

The American Liver Foundation estimates at least 25% of the US population has nonalcoholic fatty liver disease, a condition in which excess fat is stored in your liver. NAFLD is the most common chronic liver condition and currently there are no approved...